Amazon.com, Inc. stock fell sharply, but AWS growth, margin recovery, and AI investments support a strong buy case. Click for this AMZN earnings update.

The target is annual production above 4 million ounces by the early 2030s. Q3 cash flow was solid, but cost pressures increased.

Bunge Q3 2026 earnings: EPS rose, guidance held, and Viterra synergies grew despite volatility.

Microsoft reported 18.8% year-over-year revenue growth and a 39.6% net profit margin in its fiscal first quarter, lifting its Rule of 40 score to 58.4. The score reflects a strong balance between growth and profitability under the strictest version of the metric. Capital expenditure continued to climb in the quarter, giving investors reason for concern. Offsetting that pressure are the expanding Rule of 40 score and the strength of Microsoft's balance sheet.

The company's expenses declined as a share of revenue. Compute costs, its largest cost, fell from more than 250% of revenue to 48%.

The innovative medicine business posted 7.9% operational growth. TREMFYA generated $2.4 billion in quarterly sales. Those sales offset STELARA's decline.

Why CoStar stock sank 14% after earnings: revenue miss, Vexcel acquisition, and key metrics investors should watch now.

Celestica's earnings per share rose 109%, beating expectations. The company expects free cash flow to be negative in 2027. The rating on the shares remains Hold.

Celestica delivered Q3 results that exceeded estimates, with revenue up 83% YoY and EPS rising 109%. I rate CLS stock as Strong Buy. Click to read my full update.